Table 4.
Psychometric Properties of Different Breast Cancer Receptors
| Estrogen Receptors N (%) | Progesterone Receptors N% | HER2/neu Receptors N% | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Absent | Weak | Mild +ve | Moderately+ve | Strong +ve | p | Negative | Weak | Moderate +ve | Strong +ve | p | Absent | TypeI | Type IV | p | |
| BDI | |||||||||||||||
| Minimal | 0 | 0 | 0 | 0 | 2(4.1) | 0.0001 | 2(4.1) | 0 | 0 | 0 | 0.0001 | 2(4.1) | 0 | 0 | 0.07 |
| Mild | 2(4.1) | 2(4.1) | 0 | 2(4.1) | 0 | 2(4.1) | 0 | 2(4.1) | 2(4.1) | 6(12.5) | 0 | 0 | |||
| Moderate | 2(4.1) | 4(8.3) | 4(8.3) | 2(4.1) | 0 | 4(8.3) | 4(8.3) | 4(8.3) | 0 | 6(12.5) | 4(8.3) | 2(4.1) | |||
| Severe | 10 | 4(8.3) | 12 | 2(4.1) | 0 | 8(16.6) | 2(4.1) | 16 | 2(4.1) | 14(29.1) | 8(16.6) | 6(12.5) | |||
| ISI | |||||||||||||||
| No Insomnia | 4(8.3) | 0 | 0 | 0 | 2(4.1) | 0.004 | 4(8.3) | 0 | 2(4.1) | 0 | 0.19 | 4(8.3) | 2(4.1) | 0 | 0.09 |
| Subthreshold | 4(8.3) | 2(4.1) | 6(12.5) | 0 | 0 | 4(8.3) | 2(4.1) | 6(12.5) | 0 | 6(12.5) | 4(8.3) | 2(4.1) | |||
| Moderate Clinical Insomnia | 2(4.1) | 6(12.5) | 4(8.3) | 2(4.1) | 4(8.3) | 2(4.1) | 2(4.1) | 8(16.6) | 6(12.5) | 8(16.6) | 2(4.1) | 8(16.6) | |||
| Severe Clinical Insomnia | 4(8.3) | 2(4.1) | 2(4.1) | 2(4.1) | 2(4.1) | 6(12.5) | 2(4.1) | 2(4.1) | 2(4.1) | 10(20.8) | 2(4.1) | 0 | |||
| ESS | |||||||||||||||
| No Eds | 12 | 6(12.5) | 8(16.6) | 4(8.3) | 6(12.5) | 0.45 | 12(25) | 6(12.5) | 12(25) | 6(12.5) | 0.46 | 24(50) | 6(12.5) | 6(12.5) | 0.05 |
| Positive Eds | 2(4.1) | 4(8.3) | 4(8.3) | 2(4.1) | 0 | 4(8.3) | 2(4.1) | 6(12.5) | 0 | 4(8.3) | 4(8.3) | 4(8.3) | |||
| MEQ | |||||||||||||||
| Definitely Morning | 4(8.3) | 2(4.1) | 6(12.5) | 0 | 6(12.5) | 0.05 | 4(8.3) | 2(4.1) | 6(12.5) | 6(12.5) | 0.57 | 8(16.6) | 2(4.1) | 2(4.1) | 0.03 |
| Moderately Morning | 6(12.5) | 6(12.5) | 6(12.5) | 2(4.1) | 2(4.1) | 6(12.5) | 8(16.6) | 6(12.5) | 2(4.1) | 12(25) | 6(12.5) | 4(8.3) | |||
| Neither | 4(8.3) | 0 | 2(4.1) | 2(4.1) | 0 | 4(8.3) | 2(4.1) | 2(4.1) | 0 | 6(12.5) | 2(4.1) | 0 | |||
| Moderately Evening | 0 | 2(4.1) | 2(4.1) | 0 | 0 | 2(4.1) | 0 | 2(4.1) | 0 | 2(4.1) | 0 | 2(4.1) | |||
| Definitely Evening | 0 | 2(4.1) | 0 | 0 | 0 | 0 | 0 | 2(4.1) | 0 | 0 | 2(4.1) | 0 | |||
Notes: Shows comparisons among pathological subtypes of breast cancer and psychometric profile scores. It can be observed that patients with positive indices for cancer in estrogen receptors tended to have higher scores for depression on the BDI, as well as higher insomnia complaint scores on the ISI (p=0.0001 and 0.004, respectively). Positive indices for cancer in progesterone receptors were associated with elevated scores for depression on the BDI (p=0.0001) but did not show associations with insomnia complaints. Detection of cancer in HER2/neuroreceptors only affected the MEQ scores and chronotype distribution, with p=0.03. Bold values indicate statistical significance.